” To Give More Chance to life ”
The shortage of adequate organs for transplantation meets the ever-increasing demand. As a result, there has been a major increase of waiting lists. On the one hand, it is important to ensure the use of every organ, even marginal organs, which can be damaged by biological reactions and procurement and preservation techniques. On the other hand, it is important to improve transplantation outcomes.
Aferetica wants to contribute to a concrete change in the organs suitability and in the transplantation outcome
The evolution of In Situ organ reconditioning, thanks to the combination of purification systems and ECMO perfusion during organ retrieval from NHBD.
The development of complete systems for Ex-Vivo organ reconditioning, with biocompatible liquids, transport and preservation modules and sorbents for purification.
Apheresis therapies helping the patient to face inflammatory processes and immune complications before, during and after transplant